Gelnique

Gelnique is a prescription medication used to treat overactive bladder. Gelnique belongs to a group of drugs called antispasmodics, which help to relax the bladder muscle. 

This medication comes in gel form and is applied once daily.

Common side effects of Gelnique include dry mouth and application site reactions. Gelnique can also cause blurred vision and drowsiness.  Do not drive or operate heavy machinery until you know how Gelnique affects you.

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods.  In the case of Gelnique, there are no specific foods that you must exclude from your diet while receiving this medication.

Take this medication exactly as prescribed by your doctor.  Follow the directions on your prescription label carefully. 

The dose your doctor recommends may be based on the following:

• the condition being treated
• other medical conditions you have
• other medications you are taking
• how you respond to this medication
• your weight
• your height
• your age
• your gender

The recommended dose of Gelnique 3% (oxybutynin) for the treatment of overactive bladder is 3 pumps (84 mg) once daily.  The recommended dose of Gelnique 10% (oxybutynin) for the treatment of overactive bladder is 1 sachet (100 mg/g) once daily.

If you apply too much Gelnique, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away. If Gelnique is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur.  However, if an overdose is suspected, seek emergency medical attention.

Oxybutynin is used to treat symptoms of an overactive bladder, such as incontinence (loss of bladder control) or a frequent need to urinate.

The gel form is available only with a doctor's prescription. The Oxytrol® for Men skin patch is available only with a doctor's prescription, but the Oxytrol® for Women skin patch is available without a prescription or over-the counter (OTC).

• It is used to treat an overactive bladder.
• It may be given to you for other reasons. Talk with the doctor.

Use Gelnique as ordered by your doctor. Read all information given to you. Follow all instructions closely.

• Put on gel at the same time of day.
• Keep using this medicine as you have been told by your doctor or other health care provider, even if you feel well.
• Do not take Gelnique by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).
• Wash your hands before and after use.
• Wash and dry the part of the skin that the gel will be used on.
• Put on clean, dry, healthy skin on the belly, thigh, shoulder, or upper arm.
• Do not put near belly button.
• Do not use on irritated skin or if you have shaved your skin lately.
• Move the site where you put the gel each day.
• Do not bathe, shower, or swim for 1 hour after putting on.
• Avoid fire, flames, or smoking until the gel has dried.
• Do not let your skin where the gel was used touch anyone else's skin while wearing the gel. Cover the treated skin with clothes.
• Let gel dry before covering with clothing.
• Some products come in pumps. Some products come in packets. If you are using a pump, you will need to prime it before you use it the first time. Prime the pump as you are told in the package insert.

What do I do if I miss a dose?

• Put on a missed dose as soon as you think about it.
• If it is close to the time for your next dose, skip the missed dose and go back to your normal time.
• Do not put on 2 doses or extra doses.

• Store at room temperature.
• Protect from light.
• Store in a dry place. Do not store in a bathroom.
• Protect from heat.
• Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.
• Check with your pharmacist about how to throw out unused drugs.

Gel: 10%

Overdosage with oxybutynin has been associated with anticholinergic effects including central nervous system excitation, flushing, fever, dehydration, cardiac arrhythmia, vomiting, and urinary retention. Oral ingestion of 100 mg oxybutynin chloride in association with alcohol has been reported in a 13-year-old boy who experienced memory loss, and in a 34-year-old woman who developed stupor, followed by disorientation and agitation on awakening, dilated pupils, dry skin, cardiac arrhythmia, and retention of urine. Both patients recovered fully with symptomatic treatment.

Plasma concentrations of oxybutynin begin to decline 24 hours after Gelnique application. If overexposure occurs, monitor patients until symptoms resolve.